|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,050 GBX | -0.87% |
|
+0.52% | +13.68% |
| May. 03 | Angle shares up on assay development deal with AstraZeneca | AN |
| May. 03 | Angle shares up on assay development deal with AstraZenaca | AN |
TOKYO, May 21 (Reuters) - Japan is likely to hold off on administering AstraZeneca PLC's COVID-19 vaccine despite expected approval on Friday, amid concerns about blood clots, public broadcaster NHK and other media reported.
The government it also expected to formally approve on Friday the COVID-19 vaccine developed by Moderna Inc as it seeks to speed up what has been the slowest vaccination campaign among rich countries. (Reporting by Chang-Ran Kim; Editing by Jacqueline Wong)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 5,502 JPY | +3.13% | +9.82% | 69B | ||
| 4,125 JPY | -0.43% | +0.88% | 42.33B | ||
| 806 JPY | -0.86% | +1.13% | 658M | ||
| 125 USD | -0.47% | +15.77% | 47.9B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +13.68% | 234B | |
| +26.08% | 662B | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 289B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| +8.08% | 167B | |
| -3.40% | 157B |
ASTRAZENECA PLC 
